PCV31 COST-EFFECTIVENESS OF ACHIEVING ADDITIONAL LIPID TARGETS WHEN SUBSTITUTING FENOFIBRATE 145 MG FOR STANDARD FENOFIBRATE THERAPY
May 1, 2007, 00:00
10.1016/S1098-3015(10)68675-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)68675-5/fulltext
Title :
PCV31 COST-EFFECTIVENESS OF ACHIEVING ADDITIONAL LIPID TARGETS WHEN SUBSTITUTING FENOFIBRATE 145 MG FOR STANDARD FENOFIBRATE THERAPY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)68675-5&doi=10.1016/S1098-3015(10)68675-5
First page :
Section Title :
Open access? :
No
Section Order :
448